Results 21 to 30 of about 7,668 (229)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis

open access: yesClinical Ophthalmology, 2013
Masahiro Miura,1,2 Takuya Iwasaki,1,2 Hiroshi Goto2 1Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, Ami, Ibaraki, Japan; 2Department of Ophthalmology, Tokyo Medical University, Nishi-Shinjuku, Tokyo, Japan Purpose: To ...
Miura M, Iwasaki T, Goto H
doaj   +1 more source

Choroidal Nevus in an Eye with Polypoidal Choroidal Vasculopathy

open access: yesCase Reports in Ophthalmology, 2014
Purpose: To report an eye with polypoidal choroidal vasculopathy (PCV) and a choroidal nevus. Methods: This is an observational case report. Results: A healthy 69-year-old woman was referred to the Osaka University Hospital with a diagnosis of a macular ...
Kazunobu Asao   +2 more
doaj   +2 more sources

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization

open access: yesClinical Ophthalmology, 2017
Chavakij Bhoomibunchoo,1 Yosanan Yospaiboon,1 Somanus Thoongsuwan,2 Duangnate Rojanaporn,3 Nawat Watanachai,4 Pichai Jirarattanasopa,5 Nattapon Wongcumchang,6 Atchara Amphornphruet,7 Sritatath Vongkulsiri,8 Eakkachai Arayangkoon9 1Department of ...
Bhoomibunchoo C   +9 more
doaj   +1 more source

Photodynamic therapy for polypoidal choroidal vasculopathy secondary to choroidal nevus

open access: yesInternational Medical Case Reports Journal, 2017
James G Wong,1–3 Xin Jie Lai,1 Richard Y Sarafian,4 Hon Seng Wong,5 Jeremy B Smith6 1Strathfield Retina Clinic, Sydney, NSW, Australia; 2Medical Retina Unit, Sydney Eye Hospital, Sydney, NSW, Australia; 3Save Sight Institute, University of Sydney ...
Wong JG   +4 more
doaj   +3 more sources

Polypoidal choroidal vasculopathy: a comprehensive clinical update

open access: yesTherapeutic Advances in Ophthalmology, 2019
Polypoidal choroidal vasculopathy as a disease is yet to be comprehended completely. The clinical features consisting of huge serosanguineous retinal pigment epithelial and neurosensory layer detachments, although unique may closely mimick neovascular ...
Atul Kumar   +8 more
doaj   +2 more sources

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients

open access: yesClinical Interventions in Aging, 2009
Dimitrios A Karagiannis, Vasilios Soublis, Artemios Kandarakis1st Ophthalmology Department of Ophthalmiatrio Eye Hospital of Athens, Athens, GreeceBackground: To report a case of peripheral polypoidal choroidal vasculopathy (PCV) which was treated ...
Dimitrios A Karagiannis   +2 more
doaj   +1 more source

Polypoidal choroidal vasculopathy

open access: yesJournal of Retina-Vitreous, 2023
Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy characterized by multiple recurrent serosanguineous retinal pigment epithelial detachments (PED).
Blair, Kyle   +2 more
core   +5 more sources

CURRENT ASPECTS OF DIAGNOSIS AND TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY

open access: yesОфтальмохирургия, 2017
Polypoidal choroidal vasculopathy (PCV) is the rare subtype of agerelated macular degeneration (AMD), which  is hard to diagnose and it is resistant to standard anti-VEGF treatment of AMD.
A. V. Doga   +3 more
doaj   +3 more sources

Polypoidal Choroidal Vasculopathy: An Update on Diagnosis and Treatment

open access: yesClinical Ophthalmology, 2023
Polypoidal choroidal vasculopathy (PCV) is a vascular disease of the choroid that leads to hemorrhagic and exudative macular degeneration. It may cause significant vision loss and thus affect the quality-of-life and psychological well-being. Non-invasive,
P. Sen   +4 more
semanticscholar   +1 more source

New Concepts for the Diagnosis of Polypoidal Choroidal Vasculopathy

open access: yesDiagnostics, 2023
Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (nAMD) that is characterized by a branching neovascular network and polypoidal lesions.
Jinzhi Zhao   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy